TCBP Insider Trading

Insider Ownership Percentage: 15.80%
Insider Buying (Last 12 Months): $23,923.45
Insider Selling (Last 12 Months): $0.00

TC Biopharm Insider Trading History Chart

This chart shows the insider buying and selling history at TC Biopharm by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TC Biopharm Share Price & Price History

Current Price: $5.68
Price Change: Price Increase of +0.28 (5.19%)
As of 02/3/2023 01:00 AM ET

This chart shows the closing price history over time for TCBP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

TC Biopharm Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/24/2022Kenneth Edward RandallMajor ShareholderBuy20,803$1.15$23,923.45100,418View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for TC Biopharm (NASDAQ:TCBP)

66.72% of TC Biopharm stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TCBP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

TC Biopharm Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/14/2022Renaissance Technologies LLC146,400$41K0.0%+581.7%0.385%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC130,005$35K0.0%+454.0%0.342%Search for SEC Filing on Google Icon
8/22/2022Legal & General Group Plc207,258$76K0.0%N/A0.544%Search for SEC Filing on Google Icon
8/15/2022KCL Capital L.P.100,000$37K0.0%N/A0.263%Search for SEC Filing on Google Icon
8/11/2022Warberg Asset Management LLC99,165$36K0.0%N/A0.261%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
TC Biopharm logo
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Read More on TC Biopharm

Today's Range

Now: $5.68
Low: $5.51
High: $6.15

50 Day Range

MA: $4.41
Low: $3.10
High: $6.30

52 Week Range

Now: $5.68
Low: $2.81
High: $175.00


810,056 shs

Average Volume

3,075,237 shs

Market Capitalization

$5.40 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of TC Biopharm?

TC Biopharm's top insider investors include:
  1. Kenneth Edward Randall (Major Shareholder)
Learn More about top insider investors at TC Biopharm.